Monoclonal Antibodies Market (2012 - 2017)
Report Code: UC 1692 Oct, 2023, by marketsandmarkets.com
The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008. Monoclonal antibodies present significant opportunities as they are targeted therapy (They impact only the diseased cells and do not harm healthy cells) unlike chemotherapy drugs. This results in reduced side effects and increased effectiveness. Cancer in one of the significant application area for mAbs. However, price correction would enable significant shift of usage from traditional chemotherapy drugs to mAbs
Request for detailed table of content.
Request for detailed methodology, assumptions & how numbers were triangulated.
Growth opportunities and latent adjacency in Monoclonal Antibodies Market